Ginger Gregory - 07 Feb 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Feb 2024, 20:14:54 UTC
Prior SEC filing
31 Jan 2024
Next SEC filing
13 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wendell Taylor, attorney in fact for Ginger Gregory

Key filing fact

Ginger Gregory filed Form 4 for BIOGEN INC. (BIIB) on 09 Feb 2024.

Key facts

  • This page summarizes Ginger Gregory's Form 4 filing for BIOGEN INC. (BIIB).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 09 Feb 2024, 20:14.

Change

  • Previous filing in this sequence was filed on 31 Jan 2024.
  • Current net transaction value: -$119,669.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIIB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,635
Change %
+19%
Price
$0.000000
Shares after
10,118
Date
08 Feb 2024
Ownership
Direct
BIIB transaction

Common Stock

Tax liability

Transaction value
$119,669
Shares
-498
Change %
-4.9%
Price
$240.30
Shares after
9,620
Date
08 Feb 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIIB transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+5,405
Change %
Price
$0.000000
Shares after
5,405
Date
07 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,405
Exercise price
$0.000000
Footnotes
F1
BIIB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-1,635
Change %
-33%
Price
$0.000000
Shares after
3,270
Date
08 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,635
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Footnote F2

The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .